2026 Q2 Portfolio Activity
In 2026 Q2, Exome Asset Management LLC maintained a portfolio of 71 distinct positions. The most significant new addition was TG THERAPEUTICS INC, now representing 5.59% of the total fund value. They heavily accumulated shares in CRESCENT BIOPHARMA INC., increasing the position by 409.0%. Conversely, Exome Asset Management LLC completely exited their position in SPDR SERIES TRUST.
Position History
hover any row below to update
Loading…
Total Positions
71
Quarter
2026 Q2
Top Holding
GH (6.2%)
Top 10 Concentration
44.6%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 71
Exome Asset Management LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GH
GUARDANT HEALTH...
|
Healthcare | 6.25% | 3.95% |
#1
5
Prev: #6
|
5.0 |
—
|
-15,236 | -18.4% |
P
S
|
67,500 | $10,127,025 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 5.62% | 7.58% |
#2
1
Prev: #1
|
3.7 |
—
|
-18,264 | -40.2% |
P
S
|
27,205 | $9,107,962 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TGTX
TG THERAPEUTICS...
|
Healthcare | 5.59% | — |
#3
Prev: #—
|
6.7 |
—
|
164,915 | — |
NEW
|
164,915 | $9,060,430 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 5.03% | 5.54% |
#4
2
Prev: #2
|
2.5 |
—
|
-68,010 | -24.4% |
P
S
|
210,523 | $8,147,240 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 4.31% | 4.27% |
#5
1
Prev: #4
|
2.7 |
—
|
-21,887 | -19.9% |
P
S
|
88,177 | $6,991,554 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 4.06% | 3.34% |
#6
2
Prev: #8
|
1.6 |
—
|
-1,520 | -21.7% |
P
S
|
5,492 | $6,587,270 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 3.85% | — |
#7
Prev: #—
|
5.0 |
—
|
46,878 | — |
NEW
|
46,878 | $6,246,962 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALMS
ALUMIS INC
|
Healthcare | 3.55% | 3.18% |
#8
1
Prev: #9
|
1.4 |
—
|
-74,758 | -26.8% |
P
S
|
204,418 | $5,752,323 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 3.16% | 3.54% |
#9
2
Prev: #7
|
1.3 |
—
|
-43,662 | -42.1% |
P
S
|
60,056 | $5,116,171 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 3.14% | 4.46% |
#10
7
Prev: #3
|
1.3 |
—
|
-119,888 | -54.5% |
P
S
|
100,203 | $5,085,302 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VERA
VERA THERAPEUTI...
|
Healthcare | 2.57% | 2.39% |
#11
Prev: #11
|
1.5 |
—
|
-17,715 | -15.4% |
P
S
|
97,276 | $4,174,113 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 2.46% | 1.80% |
#12
8
Prev: #20
|
1.0 |
—
|
-3,250 | -25.3% |
P
S
|
9,612 | $3,995,036 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TXG
10X GENOMICS IN...
|
Healthcare | 2.43% | 1.69% |
#13
10
Prev: #23
|
1.0 |
—
|
-51,565 | -33.4% |
P
S
|
102,629 | $3,934,796 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NTRA
NATERA INC
|
Healthcare | 2.31% | 1.93% |
#14
4
Prev: #18
|
0.9 |
—
|
-4,850 | -26.0% |
P
S
|
13,800 | $3,746,010 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
QURE
UNIQURE NV
|
Healthcare | 2.30% | — |
#15
Prev: #—
|
4.4 |
—
|
81,056 | — |
NEW
|
81,056 | $3,733,439 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 2.21% | 1.83% |
#16
3
Prev: #19
|
0.9 |
—
|
-8,372 | -20.6% |
P
S
|
32,209 | $3,576,165 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 2.11% | 1.37% |
#17
16
Prev: #33
|
3.3 |
—
|
26,182 | 29.6% |
P
S
|
114,692 | $3,422,409 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GLUE
MONTE ROSA THER...
|
Healthcare | 2.05% | 1.53% |
#18
9
Prev: #27
|
0.8 |
—
|
-42,369 | -23.6% |
P
S
|
137,115 | $3,318,183 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MLTX
MOONLAKE IMMUNO...
|
Healthcare | 2.00% | 2.08% |
#19
3
Prev: #16
|
0.8 |
—
|
-48,883 | -22.7% |
P
S
|
166,493 | $3,241,619 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ALKS
ALKERMES PLC
|
Healthcare | 1.98% | 1.54% |
#20
5
Prev: #25
|
0.8 |
—
|
-22,767 | -27.1% |
P
S
|
61,336 | $3,213,700 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LQDA
LIQUIDIA CORPOR...
|
Healthcare | 1.93% | 0.89% |
#21
20
Prev: #41
|
1.3 |
—
|
-6,572 | -14.4% |
P
S
|
39,224 | $3,127,330 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 1.81% | 2.16% |
#22
7
Prev: #15
|
0.7 |
—
|
-1,643 | -23.3% |
P
S
|
5,410 | $2,931,300 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GKOS
GLAUKOS CORP
|
Healthcare | 1.71% | 1.16% |
#23
14
Prev: #37
|
1.2 |
—
|
-1,012 | -4.8% |
P
S
|
19,862 | $2,775,913 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 1.62% | 1.48% |
#24
6
Prev: #30
|
0.6 |
—
|
-13,507 | -29.5% |
P
S
|
32,214 | $2,625,763 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AGIO
AGIOS PHARMACEU...
|
Healthcare | 1.61% | 2.19% |
#25
11
Prev: #14
|
0.6 |
—
|
-54,560 | -43.6% |
P
S
|
70,500 | $2,616,255 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
CRESCENT BIOPHA...
|
|
Unknown | 1.42% | 1.46% |
#26
5
Prev: #31
|
1.1 |
—
|
-25,422 | -16.6% |
P
S
|
127,769 | $2,299,842 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
AZNCF
ASTRAZENECA PLC
|
Unknown | 1.39% | — |
#27
Prev: #—
|
4.1 |
—
|
12,045 | — |
NEW
|
12,045 | $2,254,128 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BSX
BOSTON SCIENTIF...
|
Healthcare | 1.27% | 1.57% |
#28
4
Prev: #24
|
1.5 |
—
|
no change | no change |
P
S
|
48,347 | $2,063,450 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ADAG
ADAGENE INC
|
Healthcare | 1.27% | 1.49% |
#29
Prev: #29
|
0.5 |
—
|
-248,552 | -33.7% |
P
S
|
488,293 | $2,050,831 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PEN
PENUMBRA INC
|
Healthcare | 1.23% | 1.07% |
#30
9
Prev: #39
|
1.5 |
—
|
no change | no change |
P
S
|
6,300 | $1,989,225 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 1.20% | 1.52% |
#31
3
Prev: #28
|
0.5 |
—
|
-1,450 | -22.8% |
P
S
|
4,908 | $1,951,813 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VKTX
VIKING THERAPEU...
|
Healthcare | 1.15% | — |
#32
Prev: #—
|
4.0 |
—
|
47,861 | — |
NEW
|
47,861 | $1,867,058 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 1.10% | — |
#33
Prev: #—
|
3.9 |
—
|
181,588 | — |
NEW
|
181,588 | $1,783,194 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EQ
EQUILLIUM INC
|
Healthcare | 1.09% | — |
#34
Prev: #—
|
3.9 |
—
|
552,956 | — |
NEW
|
552,956 | $1,769,459 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ASCENDIS PHARMA...
|
|
Unknown | 1.08% | — |
#35
Prev: #—
|
3.9 |
—
|
6,573 | — |
NEW
|
6,573 | $1,753,151 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
CRBP
CORBUS PHARMACE...
|
Healthcare | 1.07% | 1.14% |
#36
2
Prev: #38
|
0.4 |
—
|
-49,222 | -21.0% |
P
S
|
184,914 | $1,734,493 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 1.06% | 1.27% |
#37
3
Prev: #34
|
0.9 |
—
|
-61,401 | -11.8% |
P
S
|
460,067 | $1,725,251 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VSTM
VERASTEM INC
|
Healthcare | 1.01% | 1.75% |
#38
16
Prev: #22
|
0.4 |
—
|
-207,659 | -32.6% |
P
S
|
429,041 | $1,638,937 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NKTR
NEKTAR THERAPEU...
|
Healthcare | 0.97% | — |
#39
Prev: #—
|
3.9 |
—
|
22,417 | — |
NEW
|
22,417 | $1,564,931 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CLPT
CLEARPOINT NEUR...
|
Healthcare | 0.92% | — |
#40
Prev: #—
|
3.9 |
—
|
83,636 | — |
NEW
|
83,636 | $1,492,066 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INSM
INSMED INC
|
Healthcare | 0.91% | 2.25% |
#41
29
Prev: #12
|
0.4 |
—
|
-12,778 | -47.9% |
P
S
|
13,873 | $1,479,139 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CAI
CARIS LIFE SCIE...
|
Healthcare | 0.86% | — |
#42
Prev: #—
|
3.8 |
—
|
78,180 | — |
NEW
|
78,180 | $1,393,168 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 0.84% | 2.59% |
#43
33
Prev: #10
|
0.3 |
—
|
-49,133 | -72.8% |
P
S
|
18,359 | $1,367,378 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZBIO
ZENAS BIOPHARMA...
|
Healthcare | 0.82% | 0.82% |
#44
2
Prev: #42
|
0.3 |
—
|
-28,287 | -35.0% |
P
S
|
52,443 | $1,331,003 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IMAB
NOVABRIDGE BIOS...
|
Unknown | 0.69% | 0.73% |
#45
1
Prev: #44
|
1.3 |
—
|
no change | no change |
P
S
|
576,960 | $1,125,072 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ESTA
ESTABLISHMENT L...
|
Healthcare | 0.69% | 0.38% |
#46
5
Prev: #51
|
1.3 |
—
|
no change | no change |
P
S
|
13,100 | $1,124,111 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 0.55% | 1.43% |
#47
15
Prev: #32
|
0.2 |
—
|
-230,771 | -82.9% |
P
S
|
47,531 | $889,305 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GERN
GERON CORP
|
Healthcare | 0.49% | — |
#48
Prev: #—
|
3.7 |
—
|
624,046 | — |
NEW
|
624,046 | $798,779 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DRUG
BRIGHT MINDS BI...
|
Healthcare | 0.44% | — |
#49
Prev: #—
|
3.7 |
—
|
10,110 | — |
NEW
|
10,110 | $709,722 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 0.37% | — |
#50
Prev: #—
|
3.6 |
—
|
276,165 | — |
NEW
|
276,165 | $604,801 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 71 holdings